| |
|
Form Serial Number: |
DA20190725E00282
|
| 1.
Date of relevant event: |
23/07/2019
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
01951 |
| 4.
Name of listed corporation: |
Jinxin Fertility Group Ltd. |
| 5.
Class of shares: |
Ordinary Shares |
| 6.
Number of issued shares in class: |
2,434,383,802 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
Wilcox |
| (Other names) |
John Gorden |
|
|
|
| 10.
Name of director (Chinese): |
|
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 1213 | The number of shares in which you are interested has reduced because:
any other event (you must briefly describe the relevant event in the Supplementary Information box) |
|
| 2201 | Interest of corporation controlled by you |
|
| 2201 | Interest of corporation controlled by you |
|
53,568,000 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 360,725,005 | 15.15 |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 360,725,005 | 14.82 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| 2201 | Interest of corporation controlled by you |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | | |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| John G. Wilcox, M.D., A Medical Corporation | 875 S Madison Ave, Pasadena, CA 91106 (United States of America) | John Gorden Wilcox | 100.00 | Y | |
| HRC Investment Cayman, LLC | Cricket Square, Hutchins Drive, P.O. Box 2681, Grand Cayman KY1-1111, Cayman Islands (Cayman Islands) | John G. Wilcox, M.D., A Medical Corporation | 23.65 | Y | |
| HRC Investment Holding, LLC | 135 South Rosemead Blvd, Pasadena CA, United States (State of Delaware) | HRC Investment Cayman, LLC | 100.00 | Y | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| | | |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| Bradford Alan Kolb | Addresses of individuals are not displayed. | 360,725,005 |
| Robert Boostanfar | Addresses of individuals are not displayed. | 360,725,005 |
| Daniel Alan Potter | Addresses of individuals are not displayed. | 360,725,005 |
| Jane Leigh Frederick | Addresses of individuals are not displayed. | 360,725,005 |
| David Tourgeman | Addresses of individuals are not displayed. | 360,725,005 |
| Jeffrey Robert Nelson | Addresses of individuals are not displayed. | 360,725,005 |
| Michael Alan Feinman | Addresses of individuals are not displayed. | 360,725,005 |
| Total number of shares in which a director is interested under sections 317 and 318 | 360,725,005 |
|
| |
| 34.
Supplementary information: |
The issue and allotment of the Over-allotment Shares resulting in the percentage figure of Dr. John Gorden Wilcox's interest in the shares of Jinxin Fertility Group Limited crossing over a whole percentage number from 15.15% to 14.82%
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
0
|
|
Date of filing this Form 3A: |
25/07/2019
(dd/mm/yyyy)
|
| |